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Over the past few years, it has become apparent that a large number of transmembrane signaling systems 
operate through heterotrimeric G-proteins ([l] Gilman, A.G. (1984) Cell 36,577-579; [2] Baker, P.F. (1986) 
Nature 320, 395). Adenylate cyclase is regulated by stimulatory hormones through Gs(a&) and inhibitory 
hormones through Gi(C$y) ([2]; Katada, T. et al. (1984) J. Biol. Chem. 259,35863595), whereas the break- 
down of phosphatidylinositol bisphosphate (PIP3 to inositol trisphosphate (IPJ and diacylglycerol (DG) 
by phospholipase C is probably also mediated by a heterotrimeric G-protein (G, or G,) [ 1,2]. Similarly, the 
activation of cGMP phosphodiesterase by light-activated rhodopsin is mediated through the heterotrimeric 
G-protein transducin (Stryer, L. (1986) Rev. Neurosci. 9, 89-l 19). Other transmembrane signaling systems 
may also be found to involve G-proteins similar to those already recognized. Because of the emerging uni- 
versality of G-proteins as transducers of receptor-triggered signals, it may be useful to evaluate the current 
models prevailing in the adenylate cyclase field, as these models seem to guide our way in evaluating the 
role of G-proteins in transmembrane signaling, in general. 
G-protein; Adenylate cyclase; Receptor 
1. INTRODUCTION 
G-proteins are heterotrimeric proteins composed 
of three subunits: a GTP-binding subunit LY-, fl- 
and y-subunits. These proteins function in trans- 
membrane signaling of hormones, neurotrans- 
mitters and light (transducin) [l]. The molecular 
mechanism of G-protein action as a transducer 
between the receptor and its biochemical effector 
system is believed to be similar in all heterotrimeric 
G-proteins. Detailed studies on the hormonal 
regulation of adenylate cyclase through the stim- 
ulatory G-protein, G,, and the inhibitory G- 
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protein, Gr (reviews [1,3]), provided a popular 
molecular model promoted mainly by Gilman and 
his colleagues [I ,3]. The model (fig. 1) is mainly 
based on the observation that the stimulatory G- 
protein, G,, dissociates in the presence of the non- 
hydrolyzable analog, GTPyS, to produce a 
GTPyS-bound cy,(Gscu)-subunit which is sufficient 
to activate the purified catalytic unit of adenylate 
cyclase (C) [5]: 
cu,Py + GTPyS 
Mg2+ 
- Cy,orn+ + fly (1) 
&=P* + c - &=P* .c (2) 
Similarly, the m-subunit of transducin, when 
bound with the non-hydrolyzable guanyl 
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nucleotide GppNHp, is sufficient to activate the 
rod outer-segment cGMP phosphodiesterase [6]: 
&pNHP + PDE - ~~~pNHp - PDE (3) 
GTPyS has also been shown to activate the 
breakdown of phosphatidylinositol bisphosphate 
(PIPz) to the second messengers diacylglycerol 
(DG) and inositol trisphosphate (IPs) [7], which by 
analogy implies an interaction of a GLY that is as yet 
undefined but may be G& 181 with a specific 
phospholipase C [9]. Support for the involvement 
of G-proteins in the activation of phospholipase C 
is abundant [g-12]. 
Gi, a heterotrimeric G-protein which mediates 
hormonal inhibition, can also [1,3,13-151 
dissociate to its GTPyS-bound cri with the release 
of &-subunits: 
(Y@T + GTPyS 
Mg2+ 
- crpTp* + py (4) 
So far it has not been possible to demonstrate a 
Gi + or an ai - cyclase complex. Since the fly-subunit 
of Gi seems to be identical to the &subunit of Gs 
1161, the suggestion that Gi confers inhibition on 
adenylate cyclase through the release of &Y- 
subunits with no direct ai_C interaction f1,3] is 
very attractive, as explained below. 
2. THE G-DISSOCIATION MODEL FOR 
ADENYLATE CYCLASE REGULATION 
The G-dissociation model for adenylate cyclase 
regulation by hormones suggests (fig.1) that: 
(i) Stimulation of adenylate cyclase occurs as 
follows: The agonist-bound stimulatory receptor 
catalyzes the GDP-GTP exchange on G,, and Gs 
dissociates to (yyTP and fly. agTP seeks the 
adenylate cyclase catalyst C and activates it. Upon 
GTP hydrolysis, &jDp dissociates from C and 
reassociates to form the GDP-bound heterotrimer 
a$jDP *fly. A new cycle of G, activation by the 
stimulatory hormone can now begin. 
(ii) Inhibition of adenylate cyclase occurs as 
follows: The agonist bound at the inhibitory recep- 






Fig. 1. The G-dissociation mode1 for adenylate cyclase 
regulation. Interaction of a stimulatory receptor Rs 
bound with an agonist H, with Gs in its resting GDP- 
bound state and in the presence of GTP leads to its 
dissociation. The active aFTP released from the 
heterotrimer combines with the catalytic unit C and 
activates it to the CAMP-producing form. The fly- 
subunits compete with C for LUS. When GTP is 
hydrolyzed at the oFTp. C complex to form &FDP. C, the 
complex is dissociated to aFDp and C and the former 
recombines with& to reform the inactive G,. According 
to this model, the intramembranous concentration of the 
&-subunits determines the level of adenylate cyclase 
activity, since they compete with the catalyst C for oyTp. 
When the inhibitor G-protein Gr is activated by 
interacting with an inhibitory receptor Ri bound with an 
agonist Hi, it dissociates to opTiTp and fly. This reaction 
leads to an increase in the intramembranous 
concentration of ,& and, therefore, to adenylate cyclase 
inhibition. The two basic features of the model are: (i) 
all 5 components, R,, Ri, G,, Gr and C, are physically 
separate and interact with each other. This type of 
interaction leads to a complex kinetic pattern of 
activation, typical for the ‘shuttle’ models (see text). (ii) 
The native form of the enzyme C, while its active form 
is aFTP.C. 
dissociates to ayTP and fly_ The fly-subunits re- 
leased elevate their level within the bilayer, thus 
causing a more effective scavenging of as, with an 
effective cyclase inhibition. 
The model as described is depicted in fig.1 and 
is essentially the model described by Katada et al. 
[3]. This molecular model has achieved prominent 
status, mainly because of two features: (i) it gives 
a functional role to the fly-subunits and, because 
of their identity in Gr and G,, enables a cross-talk 
between the two G-proteins; (ii) it accounts for 
adenylate cyclase inhibition by Gi withoul the 
necessity of a direct Gi-C interaction. 
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3. EVALUATION 
A number of experimental observations do not 
fit with the dissociation model and therefore call 
for modifications or even alternative hypotheses: 
(i) The model, as it stands, treats adenylate 
cyclase as a five-component system, where all the 
functional units, R,, Ri, G,, Gi and C, are physical- 
ly separate but dynamically interact with each 
other. According to this model, cys ‘shuttles’ be- 
tween G, and C which are two physically separate 
molecules. Such a mode of interaction will yield 
complex kinetics of activation, whether GTP or a 
non-hydrolyzable analog is used [17,18]. This is in 
contrast to the experiments observation that the 
kinetics of adenylate cyclase activation by hor- 
mones and guanyl nucleotides, both in native 
membranes [IS-201 and in systems reconstituted 
from resolved components [21-241, are first order. 
Even if one assumes a moderate G,-C dissocia- 
tion, complex kinetics of activation of adenylate 
cyclase by hormones and guanyl nucleotides will 
result [17,20]. The linear dependence of the first- 
order rate constant of adenylate cyclase activation 
on the concentration of the activating receptor fur- 
ther supports the assertion that the functional enti- 
ty of adenylate cyclase is a complex between G, 
and C [17,20]. 
Biochemical studies have also shown that to 
separate G, from C, a combination of detergent 
and high salt is required [25-271. Furthermore, crs 
or even G, stay attached to C through a 240-fold 
purification as a complex when the turkey 
erythrocyte enzyme is purified in mild detergents in 
the presence of phospholipids. The complex is 
stable whether the adenylate cyclase is in its inac- 
tive, GDP-bound form or in its preactivated 
GppNHp-bound form [28]. It is feasible to modify 
the original [1,3] dissociation model and actually 
accommodate these latter findings, if one assumes 
that tys is always associated with C and the fly- 
subunits dissociate from the G,. C complex, leav- 
ing behind CQ. C [29]. This modified [29] dissocia- 
tion model (fig.2) does not conflict with the basic 
kinetic properties of the complete system and still 
retains its basic feature, namely, a central role for 
the fly-subunits as the regulators of adenylate 
cycIase activity. 
Recent experiments on the light-catalyzed cGMP 
phosphodiesterase (PDE) in rod disk membranes 
Qi 
octwe 
Fig.2. The modified G-dissociation model. In this 
model, it is assumed that the cu,-subunit is physically 
attached to the catalyst C at all times. The active form 
of the enzyme is aPTP .C and its inactive form 
y/9ffgDP * C. Like in the dissociation model (fig.l), the 
intramembranous concentration of the &-subunits 
determines the level of adenyiate cyclase activity. The 
absence of a complete dissociation between LY~ and C 
allows simple overall kinetics of activation, and 
therefore is the minimal modification required for the 
dissociation model in order to accommodate it with the 
kinetic results obtained for hormonally regulated 
adenylate cyclase in native membranes as well as 
hormone-sensitive adenylate cyclase reconstituted from 
purified components (see text). 
also suggest hat the G-protein is associated with 
the catalyst PDE during the entire cycle of its ac- 
tivation by light-excited rhodopsin [30]. 
(ii) In T-cell S49 lymphoma cell AC- {cyc-) 
variant, normal hormonal inhibition is observed 
but hormonal stimulation is nullified because of 
the complete absence of G,. The ability of 
somatostatin to inhibit adenylate cyclase through 
Gi in S40 cyc- cells [31] argues for a direct Gi-C 
interaction. Kinetic studies performed on the 
S49AC membranes, into which increasing 
amounts of G, have been inserted, also suggests 
that G, and Gi interact at independent domains of 
C [32]. As indicated above, no Gi -C complex has 
thus far been reported. This, however, can result 
from a weak protein-protein interaction between 
Gi and C, as compared with the G,-C interaction. 
Furthermore, the experimental conditions under 
which Gi-C interactions were tested [5] may not 
have been optimal. 
(iii) As indicated above, the mode of action of 
GTP on G-proteins is frequently deduced from the 
mode of action of its non-hydrolyzable analogue 
GTPyS. It should, however, be noted that: (i) 
GTPyS permanently activates turkey erythrocyte 
115 
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adenylate cyclase, even in intact membranes, and 
cannot be ‘reversed’ by GTP and fl-adrenergic 
agonists 1331, probably because of the irreversible 
nature of the G-protein dissociation in the presence 
of GTP$S. (ii) In contrast to GTPyS, the GTP 
analogue GppNHp-activated adenylate cyclase in 
turkey erythrocytes can be reversed by GTP and fl- 
agonists or adenosine, due to a GppNHp-GTP ex- 
change [34,35]. These results have been re- 
produced in reconstituted systems: preactivated 
GgppNHp from duck erythrocytes was reconstituted 
with turkey erythrocyte ,&I-adrenoceptors, and the 
GFPPNHP could be reversed to G$jTp when the mix- 
ture was challenged with (- )-isoproterenol, GTP 
and excess of fly-subunits [23]. This result suggests 
that the purified GPppNHp tends to lose its fly- 
subunits and that the guanyl nucleotide exchange 
can occur only when the $ppNHp subunit combines 
with the &-subunits. The GppNHp-GTP ex- 
change rection is most probably catalyzed by the ,i3- 
agonist-receptor complex by a mechanism similar 
to the hormone-catalyzed GDP-GTI? exchange 
during the activation process of adenylate cyclase. 
These observations trongly suggest hat GppNHp- 
preactivated adenylate cyclase in native membrane 
possesses all three G, subunits, as, ,& and y, since 
reversal occurs with no addition of excess fly- 
subunits [35]. 
Direct me~urements of subunit dissociation of 
GppNHp-preactivated G, in detergent show that it 
occurs subsequent o G, activation [36]. It seems 
that GppNHp, which is isoelectronic and probably 
isosteric to GTP, mimics GTP more closely than 
GTPrS, excluding, of course, the GTPase ‘turn- 
off’ reaction which is absent in the GppNHp- 
activated G-proteins. 
(iv) GTP, the natural guanyl nucleotide, is 
hydrolyzed to GDP and Pi on the GTP-binding 
subunit with a rate constant of 6-15 min-” 
[18,33,37,38]. Thus, the residence time of GTP at 
its binding site as a triphosphate has a half-life of 
2.8-7 s. It is unlikely, although possible, that dur- 
ing the ‘on-off’ cycle a complete w--& separation 
takes place. It is more reasonable to assume a con- 
formational transition which involves all three 
subunits but does not necessarily involve complete 
subunit separation. 
Codina et al. [36] showed that G, as well as Gi 
can exist in an active undissociated GppNHp- 
116 
bound form which is distinct from the inactive 
GDP-bound form. Furthermore, Codina et al. [36] 
make the point that NaF and Mg2+ activate G- 
proteins reversibly without subunit dissociation. 
Indeed, during the purification of G,, NaF, A13” 
and Mg2+, which activate G,, are always present, 
and still the protein is obtained in its trimeric un- 
dissociated form 11). 
(v) The concentration dependence of adenylate 
cyclase activity on guanyl nucleotide is not com- 
plex and can be described by classical Michaelian 
kinetics ([39) and references therein; [40]). Had the 
activation of adenylate cyclase depended on Gs 
dissociations, followed by a bimolecular interac- 
tion between ,pTp and the catalytic unit: 
G, + GTP = LY:” + ,i3y (5) 
GTP L 
as - &TP.C (6) 
one would have expected a complex, non- 
Michaelian dependence of the rate of activation on 
GppNHp concentration [17,20]. In the case of 
CAMP-dependent protein kinase, where enzyme 
activation depends on a dissociation step occurring 
subsequently to CAMP binding, one indeed 
observes a characteristic kinetic pattern with a 
complex dependence on the concentration of the 
activating Iigand CAMP [41]. 
(vi) A prediction of the dissociation model [ 1,3] 
or of its modified form [29] is that activation of G- 
proteins which mediate the action of other recep- 
tors should yield adenylate cyclase inhibition. This 
is so, because the ~~-subunits of different G- 
proteins seem to be similar or identical, and their 
hypothesized release by the G-proteins should yield 
an elevation of their level within the bilayer. Only 
in one system [9] was this issue tackled directly, 
where it was shown that the activation of 
phospholipase C through a G-protein-mediated 
process by bradykinin results in a very small 
percentage of inhibition of adenylate cyclase. 
4. ALTERNATIVE MODELS 
In view of this discussion, it is apparent hat the 
molecular model which assumes that regulation of 
adenylate cyclase depends exclusively on the 
dissociation of G, and Gr suffers from certain 
severe weaknesses. It may, therefore, be necessary 
Volume 211, number 2 FEBS LETTERS January 1987 
to formulate a revised or perhaps a completely 
distinct hypothesis to account for the regulation of 
adenylate cyclase by G-proteins. Except for the 
modified G-dissociation model (fig.2) [19,29], 
there is room for completely different molecular 
models which account for the known experimental 
data. These models (fig.3) are based on the follow- 
ing assumptions: 
(i) The G,-protein does not dissociate as part of 
its mode of action. 
(ii) The G,-protein exhibits high affinity towards 
the catalyst which it regulates, and remains 
associated with it at all times. 
(iii) The complex G,. C interacts with the 
stimulatory receptor R, which, when bound with 
agonist catalyzes the GDP-GTP exchange on the 
G, . C complex. 
(iv) One receptor can catalyze the activation of 
many G, + C units. 
(v) Gi interacts either directly with C or with G, 
and confers inhibition on adenylate cyclase in a 
non-competitive manner with respect to G,. 
Two variant models are shown in fig.3. Model A 
is very similar to the model originally proposed by 
Hildebrandt et al. [42] but differs from it in 
postulating that the Gi-C interactions are weaker 
than the G,-C interactions. Model B has an impor- 
tant feature in common with the dissociation 
models, in that it postulates that Gi does not in- 
GS* CoGi Gi 0 G, l C 
I 
“~‘3 1 HI-R, jH,*Ri %Rs 
GTP IGTP 
I i 1 
activation inhibition inhibition activation 
A B 
Fig. 3. Alternative molecular models for G&-C 
interrelations. Model A: This is essentially the original 
model of interaction between the two G-proteins and the 
catalyst. It differs, however, from the symmetric 
relationship between G, and Gi vis-a-vis C, which was 
originally postulated [32]. According to the stated 
hypothesis, Gi makes a weaker (0) interaction with C 
than G, (0). Model B: In this model, Gi does not 
interact with C but rather with G,. Here, too, the Gi-G, 
interaction is weaker than the G,-C interaction. Both 
models A and B account for a non-competitive 
relationship between G, and G, at C, as observed 
experimentally [32]. 
teract with C but rather with G,. Both models A 
and B can actually account for all the experimental 
findings quoted in this article. Experimental deter- 
mination of the mode of physical interactions be- 
tween G, and Gi, and between Gi and C, would 
discriminate between the two models. It is likely 
that Gi-C or Gi-G, interactions are much weaker 
than the G,-C interaction, and have therefore 
been missed so far. Weak physical interaction is 
already known to occur between receptors and G- 
proteins ([43] and references therein). Further- 
more, it has already been pointed out that even in 
native membranes, the fl-adrenoceptor-G, cou- 
pling can be perturbed by very low concentrations 
of detergent, such as Lubrol-PX, while the G,-C 
association remains intact even at very high 
Lubrol-PX concentrations [44]. In reconstituted 
systems, where thepi-adrenoceptor, G, and C have 
been co-reconstituted, it has also been found that 
the,&adrenoceptor-G, interface is much more sen- 
sitive towards detergents than G,-C coupling [24]. 
Hence, it seems essential to optimize experimental 
protocols such that the ability of Gi to interact with 
C and/or with G, can be carefully examined. 
In summary, future experiments should be 
aimed at determining whether the dissociation of 
G, and Gi is part of their mode of action, and to 
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